Cargando…
The Diagnostic Performance of Cxbladder Resolve, Alone and in Combination with Other Cxbladder Tests, in the Identification and Priority Evaluation of Patients at Risk for Urothelial Carcinoma
Cxbladder (Cxb) tests combine genomic biomarkers in urine with phenotypic and clinical data to classify hematuria patients into those at low/high probability of urothelial carcinoma (UC). Cxbladder Resolve (CxbR) is designed for use after Cxb Triage (CxbT) and Detect (CxbD), where CxbT-positive test...
Autores principales: | Raman, Jay D., Kavalieris, Laimonis, Konety, Badrinath, Porten, Sima, Daneshmand, Siamak, Lotan, Yair, Loo, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584223/ https://www.ncbi.nlm.nih.gov/pubmed/34348469 http://dx.doi.org/10.1097/JU.0000000000002135 |
Ejemplares similares
-
Clinical Utility of Cxbladder for the Diagnosis of Urothelial Carcinoma
por: Darling, David, et al.
Publicado: (2017) -
A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion® FISH, NMP22® and cytology based on imputation of multiple datasets
por: Breen, Vivienne, et al.
Publicado: (2015) -
An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer
por: Koya, Madhusudan, et al.
Publicado: (2020) -
Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases
por: Mitra, Anirban P., et al.
Publicado: (2022) -
Clinical Utility of Cxbladder Monitor for Patients with a History of Urothelial Carcinoma: A Physician–Patient Real-World Clinical Data Analysis
por: Lough, Tony, et al.
Publicado: (2018)